rndsy-lu-2945 periodic table of neurotrophic and ... · rndsy-lu-2945 periodic table of...
TRANSCRIPT
RnDSy-lu-2945
Periodic Table of Neurotrophic and Neurotactic Factors1* 35KG/ G 95
CNTN1Contactin-1
GP135; F3; MYPCN
Notch-1; PTPRZ; NrCAM; Neurofascin 155; L1CAM; Caspr1; TNC
2* 150K1 90
Sema4FSemaphorin 4F
SEMAM; SEMAW; M-SEMA-M; S4F
ligand unknown
3* 130–140KG/ G 90
CNTN2Contactin-2
TAG1; Axonin-1; AXT; TAX1; FAME5
NCAM; NrCAM; PTPRZ; Neurocan; APP; L1CAM; Caspr2
4* 100–120K1 97
APPAmyloid b
Precursor ProteinABPP; CVAP
CNTN2, 3, 4; DR6 (CD358); APLP-1, -2; ITM2B, 2C; Integrin b1; Reelin;
Laminin; Slit2
5* 90–110K1 95
Nectin-1Poliovirus Receptor
Related 1CD111; PVRL1; PRR1;
PVRR1; HVEC; HIgR
Nectin-3; FGF R1c; SynCAM3
6* 200–250K1 83
SYND3Syndecan-3
N-Syndecan; SDC3; SDCN
Pleiotrophin; GDNF; NRTN; ARTN; Sema5A
7* 18–22KS 93
GDNFGlial Cell Line-Derived Neurotrophic Factor
ATF1; ATF2; HFB1-GDNF; HSCR3
GFRa-1, -2; SYND3
8* 250K1▲ 96
PLXNA1Plexin A1
NOV; NOVP; PLXN1
Sema3A, 3C, 3E, 3F, 5A, 5B, 6D; PLXNB1; NRP1, 2
9* 200–210K1▲ 91
PLXND1Plexin D1
PLEXD1
Sema3A, 3C, 3E, 4A; NRP1; VEGF R2
10* 100–110K1 90
Sema4GSemaphorin 4G
PLXNB2, B3
11 145–155KG/ G 91
CNTN3Contactin-3
BIG-1; PANG; PCS
PTPRG; APP; APLP-1
12* 100–120K1 89
APLP-1Amyloid b Precursor-like
Protein 1C30
CNTN3, 4, 5; APP; APLP-2
13* 80–95K1 93
Nectin-3Poliovirus Receptor
Related 3CD113; PVRL3; PRR3; PVRR3
Nectin-1, -2; SynCAM1, 3
14 200–205KS▲ 94
Slit1SLIT Homolog 1
SLIL1; MEGF4
Glypican 1; GREM1; ROBO1, 2; EVA1C
15* 12–14KS 86
NRTNNeurturin
NTN
GFRa-1, -2; SYND3
16 250K1 97
PLXNA2Plexin A2OCT; PLXN2
Sema3A, 6A, 6B; NRP1, 2
17* 95KS 95
Sema3ASemaphorin 3A
SEMA1; SEMAD; SEMAIII; COLL1; HH16; Hsema-1; Hsema-III
PLXNA1, A2, A3, A4, B1, D1; NRP1
18* 135K1▲ 93
Sema5ASemaphorin 5A
SEMAF; SemF
PLXNA1, A3, B3; SYND3
19* 125–135KG/ G 95
CNTN4Contactin-4BIG-2; AXCAM
APP; APLP-1
20* 120–135K1 91
APLP-2Amyloid b Precursor-like
Protein 2APPH; APPL2; CDEBP; WALPLP2;
YWK-II
APP; APLP-1
21* 80–90K1 98
LINGO-1LRR and Ig Domain
Containing Nogo Receptor-Interacting Protein 1
LERN1; LRRN6A
NgR; NGF R; TROY; TrkB
22 63–66K1 88
AMIGO2Amphoterin-Induced
Gene and ORF 2Alivin-1; ALI1; DEGA
AMIGO
23* 300K1 91
Notch-1Neurogenic Locus Notch
Homolog Protein 1TAN1
CNTN1, 6; Delta; Jagged 1, 2
24* 240–250K1 88
ITGA1Integrin a1CD49a; VLA-1
Laminin; Collagen; Sema7A; Integrin b1
25* 75K1SS 90
NGF RNerve Growth Factor
Receptorp75NTR; Gp80-LNGFR;
TNFRSF16; CD271
LINGO-1; NGF; BDNF; NT-3, -4; SORT1; NgR
26* 110–120K1 97
NLGN1Neuroligin 1
NL1
NRXN1a, 1b, 2a, 2b, 3a, 3b; NLGN3
27* 100–170K 89
GPC1Glypican 1
Slit1, 2; FGF basic
28* 135–140KG 95
MDGA1MAM Domain Containing
GPI Anchor 1GPIM; MAMDC3; GPI
and MAM Protein
NLGN2
29* 130–140K1/ 1 98
FGF R1cFibroblast Growth Factor
Receptor 1c N-SAM; Flt-2; bFGF-R-1; CD331;
FLG; CEK
Nectin-1; NCAM-1; N-Cadherin; multiple FGFs
30* 50–60KG 93
GFRa-1Glial Cell Line-Derived Neurotrophic Factor
Receptor a1GDNF Ra-1; TRNR1; RETL1;
GFRA1
GDNF; Ret; NRTN; ARTN
31* 95–115K1 96
SynCAM1Synaptic Cell Adhesion
Molecule 1IGSF4A; CADM1; Necl-2; TSLC1;
RA175; ST17; BL2
Nectin-3; SynCAM2, 3; FARP1; CRTAM; ErbB3; Integrin a6b4
32* 190–210KS 96
Slit2SLIT Homolog 2
SLIL3
Glypican 1; GREM1; ROBO1, 2; EVA1C; APP
33* 15–17KS 76
ARTNArtemin
Enovin; EVN; Neublastin
GFRa-1, -3; SYND3
34 220 –240K1▲ 94
PLXNA3Plexin A3
SEX; PLXN3; PLXN4; XAP-6
Sema3A, 3F, 5A, 5B; NRP1, 2
35* 95KS 97
Sema3CSemaphorin 3C
SEMAE; SemE
PLXNA1, D1; NRP1:NRP2 (heterodimer)
36* 140–150K3▲ 90
Sema5BSemaphorin 5B
SEMAG; SemG
PLXNA1, A3
37* 125–135KG/ G 90
CNTN5Contactin-5NB-2; HNB-2s
APLP-1; L1CAM
38* 150–200K1 97
NRXN1aNeurexin 1a
NLGN1, 2, 3, 4X, 4Y; NXPH1, 2, 3; LRRTM1, 2, 4; Granuphilin
39* 80K1▲ 98
LINGO-2LRR and Ig Domain
Containing Nogo Receptor-Interacting Protein 2
LERN3; LRRN6C
ligand unknown
40* 50–52K1 77
AMIGO3Amphoterin-Induced
Gene and ORF 3Alivin-3; ALI3
AMIGO; NgR
41* 12–13KS 85
b-NGFb-Nerve Growth Factor
NGF; NGFB; HSAN5B
NGF R; TrkA; Integrin a9b1
42 120–140K1 90
ITGA6Integrin a6
CD49f; VLA-6; Platelet gpl
Laminin; Integrin b1, b4, b6; Netrin-1; SynCAM1, 2, 4
43* 44–48K1▲ 69
TROYTNF Receptor
Superfamily, Member 19TAJ; TRADE; TNFRSF19
LINGO-1:NgR complex
44* 90–120K1▲ 98
NLGN2Neuroligin 2
NRXN1a, 1b, 2a, 2b, 3a, 3b; NLGN3; MDGA1, 2
45 190–210K1 95
ROBO1Roundabout Homolog 1
DUTT1
NRP1; ROBO2; exists in a complex for Sema3A and Sema3F; Slit1, 2, 3
46* 125–130KG 98
MDGA2MAM Domain Containing
GPI Anchor 2MAMDC1
NLGN2
47* 200K1 83
RetProto-Oncogene RTK Ret
CDHF12; CDHF16; HSCR1; MEN2A; MEN2B; MTC1;
PTC-ELE1; RET51
GFRa-1, -2, -3; PCDHA4; PCDHGB7
48* 58KG 89
GFRa-2Glial Cell Line-Derived Neurotrophic Factor
Receptor a2GDNF Ra-2; GDNFRB; TRNR2;
RETL2; GFRA2; NRTNRa
GDNF; NRTN; Ret; NCAM-1
49* 52K1 97
SynCAM2Synaptic Cell Adhesion
Molecule 2IGSF4D; CADM2; Necl-3
SynCAM1, 3, 4; Integrin a6b4
50* 200KS▲ 94
Slit3SLIT Homolog 3
SLIL2; MEGF5
ROBO1, 2
51* 13–14KS 64
PSPNPersephin
PSP
GFRa-4
52* 240–250K1▲ 98
PLXNA4Plexin A4
PLEXA4
Sema3A, 6A, 6B, 6D; NRP1, 2
53* 90–95KS 93
Sema3DSemaphorin 3D
Sema-Z2; COLL2
NRP1
54* 110–125K1 95
Sema6ASemaphorin 6ASEMAQ; Sema-VIA;
SEMA1; HT018
PLXNA2, A4
55 125–135KG/ G 89
CNTN6Contactin-6
NB3
Notch-1
56* 182K1▲ 98
NRXN2aNeurexin 2a
GABA A Rg2; NLGN1, 2, 3; Dystroglycan; NXPH1, 2, 3
57 62K1▲ 88
LINGO-3LRR and Ig Domain
Containing Nogo Receptor-Interacting Protein 3
LERN2; LRRN6B
ligand unknown
58 140K1 86
TrkANeurotrophic Tyrosine
Kinase Receptor ANTRK1; p140-TrkA; MTC
NGF; NT-3; SORT1
59* 13KS/ S/ S 97
BDNFBrain-Derived
Neurotrophic FactorIntegrin a9b1; NGF R; NCAM-1; TNC; TrkB;
TrkB:TrkC (heterodimer); NT-3, -4 (non-covalent heterodimers)
60 150–160K1 89
ITGA9Integrin a9ITGA4L; RLC-a
VCAM-1; OPN; NGF; BDNF; NT-3; Integrin b1; TNC
61* 29–31KS 99
NXPH1Neurexophilin-1
NPH1
NRXN1a, 2a, 3a
62* 110–125K1 96
NLGN3Neuroligin 3
ASPGX1; AUTSX1; HNL3; NL3; Gliotactin
NRXN1a, 1b, 2a, 2b, 3a, 3b; NLGN1, 2
63 200–210K1 94
ROBO2Roundabout Homolog 2
SAX3
ROBO1; Slit1, 2, 3
64* 120–130K1 86
PCDHA4Protocadherin a4CNRN1; CRNR1; CNR1
Ret; PCDHGB7
65* 190K1 89
c-METHepatocyte Growth
Factor ReceptorHGF R; MET; AUTS9; RCCP2;
Scatter Factor Receptor
HGF; PLXNB1, B2, B3; Sema4D
66* 50–56KG 76
GFRa-3Glial Cell Line-Derived Neurotrophic Factor
Receptor a3GDNF Ra-3; GDNFR3; GFRA3
ARTN; Ret
67* 50–60K1 95
SynCAM3Synaptic Cell Adhesion
Molecule 3IGSF4B; CADM3; Necl-1;
TSLL1; BIgR
SynCAM1, 2, 4; Nectin-1, -3
68* 70K1 97
LRRTM1Leucine-rich Repeat
Transmembrane Neuronal 1
LRRT1; LRRTM Neuronal Protein 1
NRXN1a, 1b
69* 205–225K 76
Nogo-AReticulon 4A
RTN4; RTN4A; NI220; ASY; RTN-X; NSP
NgR
70* 250–270K1▲ 87
PLXNB1Plexin B1SEP; PLXN5
Sema3A, 4C, 4D; PLXNA1, B2; c-MET; NRP1, 2; ErbB2; MSP R
71* 90–95KS 90
Sema3ESemaphorin 3E
SEMAH; M-SemaK; COLL5
PLXNA1, D1; NRP1; VEGF R2
72* 100–110K1 89
Sema6BSemaphorin 6B
SEMAN; Sema-VIB; SEM-SEMA-Y
PLXNA2, A4
73* 200–220K1 88
L1CAMNeural Cell Adhesion
Molecule L1CAML1; CD171; HSAS1;
MASA; MIC5; NgCAM; NCAM-L1; S10; SPG1
CNTN1, 2, 5; Integrin b1, b3, b5; NCAM-1
74* 178K1 98
NRXN3aNeurexin 3a
C14orf60
NXPH1, 2, 3; Dystroglycan; NLGN1, 2, 3
75 61K1▲ 94
LINGO-4LRR and Ig Domain
Containing Nogo Receptor-Interacting Protein 4
LRRN6D
ligand unknown
76* 145K1 94
TrkBNeurotrophic Tyrosine
Kinase Receptor BNTRK2; GP145-TrkB
NMDA R; BDNF; NT-3; NT-4; LINGO-1; SORT1
77* 14KS 96
NT-3Neurotrophin 3NTF3; HDNF; NGF-2
BDNF (non-covalent heterodimer); NGF R; TrkB; TrkC; Integrin a9b1; TNC;
NT-4 (non-covalent heterodimer)
78* 120–140K1 92
ITGB1Integrin b1
GPIIA; VLA-b; CD29; FNRB; MDF2; MSK12
Integrin a1-a11, aV; Laminin; Fibronectin; VCAM-1; TSP; Vitronectin; BGD motif; NGF;
BDNF; NT-3; L1CAM; APP; TNC
79 29KS 89
NXPH2Neurexophilin-2
NPH2
NRXN1a, 2a, 3a
80* 105–115K1 57
NLGN4XNeuroligin 4, X-linked
ASPGX2; AUTSX2; HNL4; HNLX; NL4
NRXN1a, 1b
81* 195–210K1▲ 81
ROBO3Roundabout Homolog 3
RIG-1; HGPPS; HGPS; RBIG1
NELL2
82* 110–120K1 82
PCDHGB7Protocadherin gB7
Ret; PCDHA4
83* 185K1 74
MSP RMacrophage Stimulating
Protein ReceptorCD136; MST1R; Ron; PTK8
MSP; PLXNB1, B2, B3; Sema4D
84* 30–32KG 57
GFRa-4Glial Cell Line-Derived Neurotrophic Factor
Receptor a4GDNF Ra-4; GFRA4
PSPN; NCAM-1
85* 55–65K1 98
SynCAM4Synaptic Cell Adhesion
Molecule 4IGSF4C; CADM4; Necl-4; TSLL2;
TSLC1-like 2
SynCAM2, 3; ErbB3; Integrin a6b4
86 75–80K1 98
LRRTM2Leucine-rich Repeat
Transmembrane Neuronal 2LRRT2; LRRN2
GluR1; NRXN1a, 1b (without an SS4 insert)
87* 95–110K1 91
SORT1Sortilin
Gp95; Neurotensin Receptor 3; Ntr3; LDLCQ6
Neurotensin; ProNGF; ProBDNF; LPL; TrkA, B, C; NGF R
88* 240–250K1 87
PLXNB2Plexin B2
MM1; PLEXB2
Sema4A, 4C, 4D, 4G; PLXNB1; c-MET; MSP R
89* 90KS 96
Sema3FSemaphorin 3F
Sema-IV; SEMA4; SEMAK
PLXNA1, A3; NRP1, 2; NrCAM
90* 110–120K1 88
Sema6CSemaphorin 6C
SEMAY; M-SemaY
NrCAM
91* 190–200K1▲ 93
NrCAMNeuronal Cell
Adhesion MoleculeBRAVO
Gliomedin; CNTN1, 2; PTPRZ; NFASC; Sema 3F, 6C, 6D
92* 180–190K1 93
Caspr1Contactin Associated
Protein-like 1CNTN; AP1; p190; NRXN4
CNTN1 (in-cis); NFASC
93* 80–85K1 89
AMIGOAmphoterin-Induced
Gene and ORFAlivin-2; ALI2; AMIGO1
AMIGO2, 3
94* 135–140K1 96
TrkCNeurotrophic Tyrosine
Kinase Receptor CNTRK3; NT-3 Growth Factor
Receptor; gp145(trkC)
NT-3; BDNF; SORT1
95 13–14KS 91
NT-4Neurotrophin 4
NT-5; NTF4; NTF5; GLC10
TrkB; NGF R; BDNF(non-covalent heterodimer); NT-3 (non-covalent heterodimer)
96* 205–210K1 83
ITGB4Integrin b4
CD104
Integrin a6; Laminin; Netrin-1; SynCAM1, 2, 4
97* 26KS 96
NXPH3Neurexophilin-3
NPH3
NRXN1a, 2a, 3a
98* 105–115K1 60
NLGN4YNeuroligin 4, Y-linked
Neuroligin 5
NRXN1a
99 125–135K1 97
N-CadherinNeural Cadherin
CD325; Cadherin-2; CDH2; CDHN; NCAD
PCDH8; FGF R1
100* 180K1G/S 94
NCAM-1Neural Cell Adhesion
Molecule-1CD56; MSK39
FGF R1; L1CAM; CNTN2; BDNF; GFRa-2, -4
101 50–52K 86
EVA1CEpithelial V-like Antigen 1
Homolog CFAM176C; SUE21; C21orf63; C21orf64; PRED34; B18; B19
Heparin; Slit1, 2
102* 200–330K S 84
TNCTenascin C
GMEM; Cytotactin; Hexabrachion f; HXB; Tenascin J1; DFNA56
Integrin a9b1; NT-3; BDNF; BMP-2; VEGF; TGF-b1; Fibronectin
103 80–85KG/ G 89
NgRNogo Receptor
Nogo-66 Receptor; NgR1; RTN4R; Reticulon 4 Receptor
OMgp; MAG; LINGO-1; TROY; AMIGO3; NGF R; Nogo-A
104* 60–70K1 97
LRRTM3Leucine-rich Repeat
Transmembrane Neuronal 3
AMPA R complex
105* 110–125K1 93
NRP1Neuropilin-1
NP1; CD304; VEGF 165 R; BDCA4
VEGF 165; Sema3A, 3B, 3C, 3D, 3E, 3F; PLXNA1, A2, A3, A4, B1, D1; NRP2;
ROBO1; VEGF R2
106* 230–260K1 84
PLXNB3Plexin B3
PLXN6; PLEXB3; PLEXR
Sema4G, 5A; c-MET; MSP R
107 100–110K1 88
Sema4CSemaphorin 4C
Sema-I; SEMAF; M-SEMA-F; SEMACL1
PLXNB1, B2
108* 130K1 95
Sema6DSemaphorin 6D
PLXNA1, A4; NrCAM
109* 180–190K1 96
NFASCNeurofascin
NF; NRCAML
Gliomedin; NrCAM; Myocilin; CNTN1; Caspr1
110* 180K1 94
Caspr2Contactin Associated
Protein-like 2CNTNAP2; CDFE; NRXN4;
AUTS15; PTHSL1
Kv1.1, 1.2; CNTN2
111 74–78K1 94
LRRTM4Leucine-rich Repeat
Transmembrane Neuronal 4LRRT4; LRRN4
AMPA R complex; GPC1–6; NRXN1a, 1b
112* 120–140K1 95
NRP2Neuropilin-2
NP2; NPN2; PRO2714; VEGF 165 R2
VEGF 165; VEGF 145; Sema3C, 3F; PLXNA1, A2; A3, A4, B1; NRP1
113 210–220K1 90
PLXNC1Plexin C1
CD232; VESPR
Sema7A
114* 140–150K1 85
Sema4DSemaphorin 4D
CD100; SEMAJ; M-SEMA-G; BB18; A8; COLL4; C9orf164
PLXNB1, B2; c-MET; ErbB2; MSP R
115* 76–80KG 89
Sema7ASemaphorin 7ACD108; H-Sema-L; SEMAL; SEMAK1;
JMH Blood Group Antigen
PLXNC1; Integrin a1b1
Table 1. Families
Note: There is no association between families and color.
I Contactin IX TNFRSF XVII IgCAM XXV SLIT
II L1CAM X Neurexophilin XVIII Tyrosine Kinase/ Protein Kinase Superfamily XXVI LRRTM
III APP XI Type B Carboxypeptidase XIX EVA1 XXVII TGF-b
IV Neurexin XII Glypican XX GDNF Receptor XXVIII Reticulon Protein
V LRRIg Protein XIII ROBO XXI Tenascin XXIX VPS10P-Related Sortilin
VI Notch XIV Type I Cadherin XXII Nectin XXX Neuropilin
VII b-NGF XV Ig/MAM/FNIII-Domain Containing Proteins XXIII Nogo Receptor XXXI Plexin
VIII Integrin a- and b-chain XVI Protocadherin a and g XXIV Syndecan Proteoglycan XXXII Semaphorin
I/II
III/IV
V V VI/VII VIII IX/X XI XII/XIII/XIV XV/XVI/XVII XVIII/XIX XX/XXI
XXII/XXIII XXIV/XXV/XXVI XXVII/XXVIII/XXIX/XXX XXXI XXXI/XXXII
XXXII
1* 135KG/ G 95
CNTN1Contactin-1
GP135; F3; MYPCN
Notch-1; PTPRZ; NrCAM; Neurofascin 155; L1CAM; Caspr1; TNC
Molecule Number
Native MWORF % aa Sequence ID (Human to Mouse)Abbreviated
Name
Receptors or Ligands
Full NameAlternate Name
Additional Information in Notes SectionStructure
NrCAM
Sema3A-D, 3F, 3G Sema3E Sema4C
cis
PLXNB3
Domain Key:
Ig-like
Sema
PSI
IPT
Split GAP
Convertase Cleavage
Tyrosine Kinase
PDZ-Binding
Basic
Meprin
GTPase-Binding
Complement-Binding
Coagulation Factor V/VIII
Ligand-Binding
Thrombospondin-like
GPI Anchor
Sema6A Sema7
PLXNB2 PLXNB1
PLXNA2Sema4D Sema5A
PLXNC1
Integrinα1β1
PLXNA4PLXNA3
NRP2
VEGF R2
c-MetSYND3
PLXND1
NRP1 PLXND1
Figure 1. Semaphorin Domain Structure and Receptor InteractionsDomain Key:
Ig-like
Coagulation Factor V/VIII
Laminin-like
EGF-like 1
Fibrinogen C-terminal
Fibronectin Type-III
PEST
Transcriptional Activation
Nuclear Localization Signal
Ankyrin/CDC10 Repeat
RAM
Lin-Notch Repeat
EGF Repeat
GPI Anchor
NrCAM NCAML1CAM L1CAM
NrCAMCaspr1
NFASC
Notch-1
CNTN1CNTN1 CNTN2 CNTN5 CNTN3 CNTN4 CNTN2CNTN1CNTN6
CNTN2Caspr2
APLP-1 APLP-1APP APP
Figure 2. Contactin Domain Structure and Receptor Interactions
(GDNF:GFRα-1)2: (NCAM-1)2
GDNF2: SYND3
GDNF2: SYND3
GDNF2: SYND3:c-Met
GDNF
GFRα-1 GFRα-2NCAM-1SYND3
SYND3
Ret
PCDHA4/PCDHGB7
(GDNF:GFRα-1)2 (GDNF:GFRα-2)2
(GDNF:GFRα-1:Ret)2 (GDNF:GFRα-2 :Ret)2
(GDNF:GFRα-1:Ret:PCDHA4/PCDHGB7)2 (GDNF:GFRα-2 :Ret:PCDHA4/PCDHGB7)2
Ret
PCDHA4/PCDHGB7
c-Met
Figure 3. GFRa-1 and GFRa-2 Ligand Interactions
Structure Key
MonomerHomodimerHomo-oligomer
HeterodimerG GPI-LinkedS Secreted
SS DisulfideBond-Linked1 Single Pass (Type I) Transmembrane3 Single Pass (Type III) Transmembrane
▲ Hypothesized structure, based on the structure of the other members in its protein family.
* Notes 1. CNTN1 has two isoforms that have open reading frames (ORFs) of 1007 amino acids (aa) and 627 aa. 2. Sema4F is found on oligodendrocytes and postsynaptic dendrites. 3. CNTN2 mutations are associated with epilepsy. 4. APP has multiple splice variants and cleavage-generated fragments. 5. There are at least two splice variants for Nectin-1. One variant is secreted with a MW of approximately 52K–54K, while the other isoform is a transmembrane protein
truncated to 458 aa. Nectin-1 dimers are important for maximizing synapse size. 6. SYND3 is attached to 100K–120K of heparin sulfate, which binds to immobilized GDNF. 7. It has been suggested that GDNF signaling may require concurrent TGF-b signaling in select cell types. There are four traditional splice variants of GDNF, which are 159 aa,
185 aa, 202 aa, and 228 aa in length. Additionally, an opposite-strand derived form of GDNF that translates into a 77 aa mature molecule also exists. 8. In general, NRPs bind Semas, while PLXNs transduce the signal. 9. PLXND1 plays a critical role in the development of basal ganglia glutamatergic signaling. 10. Sema4G is highly expressed in cerebellar Purkinje cells. 12. APLP-1 has one splice variant, which has an ORF that is 651 aa in length. Multiple cleavage isoforms arise during apoptosis. 13. Nectin-3, which is postsynpatic, binds to presynaptic Nectin-1 in-trans. Binding of Nectin-3 to Nectin-2 occurs on endothelial cells during leukocyte migration. 15. NRTN is a potent trophic factor for dopaminergic neurons. 17. Homodimeric, and not monomeric, Sema3A is active. The 95K Sema3A monomer can be cleaved between Arg555 and Gln556, generating a 65K–70K N-terminal and a
33K–50K C-terminal fragment (note: some reports state the native MW of Sema3A is approximately 125K; thus, cleavage would generate an 80K–90K N-terminal fragment). 18. Sema5a is secreted with a MW of approximately 110K. Sema5A interacts with heparin sulfate to promote cell attraction and with chrondroitin sulfate to promote cell
repulsion. 19. CNTN4 plays a key role in olfaction. There are three isoforms that have ORFs that are of 282 aa, 697 aa, and 698 aa in length. 20. APLP-2 is presynaptic while its trans-heterodimerizing partner, APLP-1 is postsynaptic. 21. LINGO-1 is a potential member of the Nogo-66 receptor complex. 23. Notch-1 undergoes cleavage at three sites: Arg1664, Gly1710 and Ala1720. 24. Unlike many Integrins, ITGA1 contains an internal “I” domain that precludes proteolysis. 25. NGF R may be cleaved to generate a 20K and 25K intracellular domain fragment that exhibit growth arrest activity. 26. NLGNs are postsynaptic proteins that bind presynaptic b-Neurexins. If NLGN1 has a site-B insert of eight aa after Glu297, it will bind only to b-Neurexins.
If this site-B insert is absent, NLGN1 will bind to both a- and b-Neurexins. Functionally, NLGNS that contain the site-B insert promote synapse formation while those that lack it promote synapse size expansion. NLGN1 is considered to be a glutamatergic NLGN.
27. GPC1 is believed to undergo cleavage to generate an 80K–100K soluble isoform. 28.MDGA1influencesinhibitorysynapsedevelopmentbybindingNLGN2in-cis and blocking its association with NRXN in-trans. 29.Therearemorethan20splicevariantsofFGFR1.FGFR1cexhibitsanunusualactivityprofile.ItisinactivewhenitbindstoNCAM-1in-cis; however, when it binds to poly-
sialylated NCAM-1 in-trans, it is active. The presence of an “acid box” (aa 126–133) is essential for FGF R1c to interact with NCAM-1 and N-Cadherin. 30. The GDNF Receptor family member GFRAL (GDNF Receptor-a-like) has been shown to be a receptor for GDF-15 and play a putative role in obesity. 31. NLGNS help form synapses, and SynCAMs lock these synapses into place. SynCAM1 binds to SynCAM3 in-trans, but it interacts with ErbB3/Her3 and Integrin a6b4 in-cis.
SynCAM1 forms glia:neuron bonds in-trans by homo-oligomerizing. Up to 50% of the MW of SynCAM1 is attributed to variable glycosylation and alternative splicing. 32. Proteolytic cleavage of Slit2 generates a 140K N-terminal and a 55K–60K C-terminal fragment. The 200K and 140K isoforms of Slit2 activate ROBOs. The 60K C-terminal
fragment binds to GPC1. Slit2 has two splice variants, which are 1521 aa and 1525 aa in length. 33. ARTN is associated with pain-sensing neurons. 35. Sema3C is cleaved at Arg745 by ADAMTS1 to generate a highly active 94K–95K polypeptide. 36. Sema5B is believed to be a type III transmembrane protein (i.e. it resembles a type I transmembrane protein but lacks a signal sequence). 37. CNTN5 has two isoforms that have ORFs that are 998 aa and 911 aa in length. 38. NRXN1a has an SS4 site that lies between aa 1241–1270. Multiple isoforms have been reported including a 73K, 442 aa b-isoform that binds “B-site” positive NLGN1.
NRXN1a promotes GABAergic synapse organization while NRXN1b promotes glutamatergic synapse organization. 39. It has been suggested that LINGO-2variationinfluencesriskandonsetageofessentialtremorandParkinson’sdisease. 40. AMIGO3 is thought to be a member of the NgR:TROY complex, which serves as the Nogo-66 receptor. 41. The b-NGF precursor consists of an N-terminal 14K proregion that is coupled to a 12K–13K mature region. When the 25K–30K proform is released, it binds to an
NGF R:SORT1 complex and induces apoptosis. Mature b-NGF does not bind to this complex. ProNGF will also bind to TrkA. 43. TROY is thought to be a marker for microglia but not macrophages. 44. NLGN2 is considered to be a GABAergic NLGN. Unlike most NLGNs, which are typically localized to postsynaptic membranes, retina NLGN is presynaptic. 46. MDGA2 has two splice variants, which are 727 aa and 1025 aa in length. 47. Ret has one splice variant, called Ret-9, that is 1072 aa in length. Ret can be cleaved after Asp707 and Asp1017. The fragment that lies between Ala708 and Asp1017
appears to be apoptotic. 48. GFR-a2 has two splice variants that are 331 aa and 359 aa in length. The shorter GFR-a2 isoform negatively regulates the activity of the full-length protein and the 359 aa
isoform. The GDNF Receptor family member GFRAL (GDNF Receptor-a-like) has been shown to be a receptor for GDF-15 and play a putative role in obesity. 49. Neuronal SynCAM2 interacts with SynCAM3 located on oligodendrocytes. 50. Slit3 has three splice variants, which are 1423 aa, 1472 aa, and 1530 aa in length. 51. The PSPN:GFRa-4complexinefficientlyrecruitsRet. 52.PLXNA4mutationsmaybeinvolvedinthepathogenesisoffamilialParkinson’sdisease.PLXNA3andPLXNA4appeartoregulateautonomicsympatheticneuronmigrationand
neurite extension. 53. Sema3D is cleaved to generate a 65K–70K fragment that is necessary for full activity. 54. Sema6A mediates granule cell migration. 56. The b splice variant of NRXN2 has a MW of 76K–80K, is 666 aa in length, and binds to NLGN1 proteins that contain the site-B insert. 59. The BDNF precursor consists of an N-terminal 16K–18K proregion that is coupled to a 13K mature region. When the 30K-32K proform is released, it binds to a NGF R:SORT1
complex, which may also interact with TrkB. ProBDNF does not bind to Trk-B. There are four BDNF splice variants, which are 255 aa, 262 aa, 276 aa, and 329 aa in length. 61. NXPHs appear to be secreted only by inhibitory neurons. NXPHs bind a-Neurexins while NLGNs bind b-Neurexins. ProNXPH1 has a MW of approximately 46–50K. 62. NLGN3 participates in both GABAergic and glutamatergic synapse development. 64. PCDHA4 has only one alternative splice variant that is 798 aa in length. Cleavage of the full-length 120K protein is believed to generate a second isoform that contains
a 75K soluble fragment plus a 40K transmembrane truncated segment. 65.Thec-METprecursorcanbecleavedtogenerateadisulfide-linkedheterodimerthatconsistsofa50Kextracellulardomain(ECD)anda140Ktransmembrane/cytoplasmic
segment.Ingeneral,therearemorethat50isoformvariantsofc-MET,manyofwhicharepresumedtobesoluble.ThenameMETisderivedfromthefirstthreeletters(methyl-) of the carcinogen that was used during its discovery.
66. Soluble GFRa-3 has a MW of approximately 50K. It has one splice variant that is 369 aa in length. The GDNF Receptor family member GFRAL (GDNF Receptor-a-like) has been shown to be a receptor for GDF-15 and play a putative role in obesity.
67. Carbohydrate moiety regulates SynCAM3 adhesive properties. 68. LRRTM1 is a postsynaptic protein that participates in excitatory synapse formation. The entire molecule is encoded by one exon, and thus, there are no splice variants. 69. There are two alternative splice variants, Nogo-B and Nogo-C, which are 373 aa and 199 aa in length, respectively. 70. PLXNB1 is cleaved to generate a 180K–200K soluble fragment and a 90K–100K membrane-bound fragment. Cleavage occurs between Arg1305 and Val1306, and the two
fragments may remain non-covalently associated. 71. Sema3E binds PLXND1 in the absence of NRPs. It is also cleaved into a 60K–61K isoform, which promotes cell migration. 72. Sema6B is found on neuronal dendrites. 73. L1CAM undergoes cleavage to generate a 35K, 85K and 140K fragment. 74. The b splice variant of NRXN3 has a MW of 80K–85K, is 668 aa in length, and shows increased binding strength to NLGNs when the SS4 site is present in the molecule. 76. Multiple isoforms of TrkB exist. 77. Human NT-3 circulates in the blood at concentrations of 5–10 pg/mL. In contrast, human BDNF circulates in the blood at a concentration of approximately 2000 pg/mL. 78. ITGB1 is one part of the Integrin a9b1 complex, which binds neurotrophins and promotes cell survival. 80. NLGN4X is an X-chromosome gene. NLGN4X mutations are associated with impaired synapse formation in autism. 81. ROBO3 is thought to also exist as a 1034 aa secreted isoform with a MW of approximately 160K. 82. PCDHGB7 is thought to serve as a signaling receptor or subunit for Ret. PCDHGB7 binds to PCDHA4 in-cis. 83.TheMSPRprecursorcanbecleavedtogenerateadisulfide-linkedheterodimerthatconsistsofa35KECDanda150Ktransmembrane/cytoplasmicfragment.Although
associatedwiththeimmunesystem,MSPisneurotrophicforNGF-responsivepainfibers.Thealternatename,Ron,isderivedfromRecepteurd’OrigineNantais(Receptor“Discovered” in Nantes, France).
84. GFRa-4 has two splice varients, which are 182 aa and 269 aa in length. The GDNF Receptor family member GFRAL (GDNF Receptor-a-like) has been shown to be a receptor for GDF-15 and play a putative role in obesity.
85. SynCAM4 is believed to not undergo splicing and is principally expressed by Schwann cells. 87. SORT1 is only active after cleavage of aa 34–77. Additional cleavage generates a 100K soluble isoform. 88. PLXNB2 is cleaved in the region between Arg1161 and Asp1165, generating a 170K soluble and 80K transmembrane fragment. It is thought that processing of PLXNB2
occurs prior to its interaction with Sema4D. 89. Sema3F binds to NRP1 but exhibits no activity. 90.Sema6Cparticipatesinsensoryneurondevelopment;however,intheadult,Sema6Cisfoundonlyonskeletalmusclefibers. 91. Cleavage of NrCAM generates a 130K–140K a-chain and a 60K-80K b-chain. There are at least 5 splice variants, which have ORFs that are 1174 aa, 1180 aa, 1192 aa,
1236 aa, and 1308 aa in length. 92. Caspr1 binds to g-secretase and blocks the conversion of Ab to Ab42. 93. AMIGO serves as a subunit for the Kv2.1 K+ channel. 94. TrkC has four splice variants that have ORFs that are 612 aa, 817 aa, 831 aa, and 825 aa in length. 96. ITGB4 has four splice variants that have ORFs that are 858 aa, 1745 aa, 1752 aa, and 1805 aa in length. 97. ProNXPH3 has a MW of approximately 41K. 98. NLGN4Y is a Y-chromosome gene whose expression is necessary for synapse formation. There are three splice variants, which are 134 aa, 256 aa, and 648 aa in length. 100. There are multiple splice variants for NCAM-1 including a “full-length” 180K isoform, a 140K transmembrane short form, a 120K GPI-linked isoform, and a 200-230K poly-
sialicacid(PSA)modifiedisoform.Non-PSA-NCAM-1formstrans-homo-oligomersthatmediatebothFGFR1dimerizationandGFRa signaling.102.HumanTNCbloodconcentrationisapproximately10–20ng/mL.Therearefivesplicevariants,whichare1655aa,1564aa,1746aa,1837aa,and2110aainlength. 104. LRRTM3 promotes APP processing by activating BACE1. There is one splice variant that is 513 aa in length.105.NRP1mayhavebothchrondroitinsulfateandheparinsulfateposttranslationalmodifications.NRP1homodimersbindtoSema3A. 106. PLXNB3 does not undergo proteolytic cleavage. PLXNB3-mediated axon guidance is responsible for language development. 108. Sema6D plays a key role in establishing contralateral and ipsilateral connections of the optic nerve. Multiple Sema6D splice variants exist, and proteolysis of the protein
generates an 80K fragment.109.NFASChasmultiplesplicevariants,twoofwhichareNF155andNF186(namesreflecttheirrespectiveMWs).NF155isfoundonoligodendrocyteswhileNF186isexpressed
in neurons. 110. Caspr2 is thought to be crucial for the proper placement of K+ channels in the nodes of Ranvier. 112. NRP2 homodimers bind Sema3F. NRP1:NRP2 heterodimers bind Sema3C. 114. Sema4D is an oligodendrocyte marker. It undergoes proteolysis to generate a circulating 130K bioactive molecule. Sema4D is also reported to use multiple RTKs for cell
signaling including MSP R and ErbB2/Her2. 115. Sema7A binding to Integrins promotes neuron migration, while Sema7A bonding to PLXNC1 blocks cell migration.
NOTE:Thisposterconveysageneraloverviewandshouldbeconsideredneithercomprehensivenordefinitive.Thedetailsofthisinformationareunderstoodtobesubjecttointerpretation.©2014R&DSystems
Global [email protected] [email protected] North America TEL 800 343 7475 Europe | Middle East | Africa TEL +44 (0)1235 529449 China [email protected] TEL +86 (21) 52380373 Rest of Worldbio-techne.com/find-us/distributorsTEL+16123792956
Learn more | rndsystems.com/neuralproteins